falseQ1April 3000017159250001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-05-012026-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:NetBookValueMemberhyft:IntellectualPropertiesMember2026-07-310001715925hyft:AccumulatedAmortizationMember2025-05-012026-04-300001715925ifrs-full:IssuedCapitalMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2026-05-012026-07-310001715925hyft:AllOtherCountriesMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2026-04-300001715925hyft:FindersWarrantsMember2026-05-012026-07-310001715925country:US2026-05-012026-07-310001715925hyft:OptionTwoMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2026-07-310001715925hyft:OptionSixMember2026-07-310001715925hyft:IdeaFamilyBVMember2026-05-012026-07-310001715925ifrs-full:LeaseLiabilitiesMember2025-07-310001715925hyft:ProjectRevenueMember2025-05-012025-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2026-04-300001715925hyft:OptionThirteenMember2026-07-310001715925hyft:DeferredAcquisitionPaymentsMember2025-05-012025-07-310001715925hyft:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2025-05-012026-04-300001715925ifrs-full:LeaseLiabilitiesMember2025-04-300001715925ifrs-full:RestrictedShareUnitsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2026-04-300001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:OptionThreeMember2026-07-310001715925ifrs-full:DiscontinuedOperationsMember2026-05-012026-07-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2026-04-300001715925hyft:LabEquipmentMemberhyft:NetBookValueMember2026-07-310001715925hyft:BioClueBVMember2025-05-012026-04-300001715925hyft:OptionEightMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925country:AU2025-05-012025-07-310001715925ifrs-full:IssuedCapitalMember2026-04-300001715925hyft:OptionFourAndFiveMember2026-07-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2026-04-300001715925country:NL2026-05-012026-07-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2026-07-310001715925ifrs-full:RestrictedShareUnitsMember2026-07-310001715925hyft:DeferredAcquisitionPaymentsMember2025-07-310001715925ifrs-full:AdditionalPaidinCapitalMember2026-07-310001715925ifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2026-05-012026-07-310001715925srt:NorthAmericaMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2026-05-012026-07-310001715925hyft:TalemTherapeuticsLLCTalemMember2026-05-012026-07-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2026-05-012026-07-310001715925ifrs-full:IssuedCapitalMember2025-07-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2026-05-012026-07-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925hyft:ProductSalesMember2026-05-012026-07-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:LaterThanFiveYearsMember2026-07-310001715925hyft:ImmunoPreciseNetherlandsBVMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2025-04-300001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2025-05-012025-07-310001715925hyft:OptionTenMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2025-04-300001715925hyft:LabAndOfficeFacilitiesMember2026-07-310001715925hyft:ImmunoPreciseAntibodiesUSALtdIPAUSAMember2026-05-012026-07-310001715925hyft:AccumulatedAmortizationMember2025-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2026-05-012026-07-310001715925hyft:NetBookValueMemberhyft:ComputerHardwareMember2026-07-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2025-05-012026-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2026-05-012026-07-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925hyft:FindersWarrantsMember2026-04-300001715925hyft:ProductSalesMember2025-05-012025-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2026-07-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925hyft:NetBookValueMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-04-300001715925ifrs-full:PotentialOrdinaryShareTransactionsMemberifrs-full:TopOfRangeMemberhyft:AtTheMarketEquityOfferingFacilityMember2025-11-072025-11-070001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2026-05-012026-07-310001715925srt:NorthAmericaMember2026-04-300001715925hyft:TalemTherapeuticsLLCTalemMember2025-05-012026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2025-05-012026-04-300001715925hyft:OptionTwelveMember2026-07-310001715925hyft:OptionOneMember2026-07-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2026-05-012026-07-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:OptionSixMember2026-05-012026-07-310001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2026-05-012026-07-310001715925hyft:FindersWarrantsMember2024-05-012025-04-300001715925hyft:DeferredAcquisitionPaymentsMember2025-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2026-07-310001715925country:BE2026-04-300001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2025-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:ImmunoPreciseAntibodiesMALLCMember2025-05-012026-04-300001715925hyft:LabEquipmentMemberifrs-full:WeightedAverageMember2026-05-012026-07-310001715925country:BE2026-05-012026-07-310001715925ifrs-full:LeaseLiabilitiesMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2026-05-012026-07-310001715925hyft:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2026-07-310001715925hyft:BioStrandBVDBAMindWalkMember2025-05-012026-04-300001715925ifrs-full:DiscontinuedOperationsMember2025-05-012025-07-310001715925hyft:LabAndOfficeFacilitiesMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2025-04-300001715925hyft:FindersWarrantsMember2025-05-012026-04-300001715925hyft:OptionSevenMember2026-07-310001715925ifrs-full:BottomOfRangeMemberhyft:LabEquipmentMember2026-05-012026-07-310001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-04-300001715925hyft:AtTheMarketEquityOfferingFacilityMember2026-04-300001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2026-05-012026-07-310001715925hyft:OptionEightMember2026-05-012026-07-310001715925hyft:NetBookValueMemberhyft:ComputerHardwareMember2026-04-300001715925hyft:LabAndOfficeFacilitiesMemberifrs-full:WeightedAverageMember2026-05-012026-07-310001715925hyft:FindersWarrantsMemberhyft:RangeOneMember2026-07-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925srt:EuropeMember2025-05-012025-07-310001715925hyft:FindersWarrantsMember2026-07-310001715925ifrs-full:RetainedEarningsMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2025-04-300001715925country:CA2025-05-012025-07-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2025-05-012026-04-300001715925hyft:ImmunoPreciseAntibodiesNDLtdMember2025-05-012026-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2025-05-012025-07-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2026-07-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-05-012025-07-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:OptionOneMember2026-05-012026-07-310001715925hyft:OptionElevenMember2026-07-310001715925srt:EuropeMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2026-05-012026-07-310001715925ifrs-full:VehiclesMemberifrs-full:WeightedAverageMember2026-05-012026-07-310001715925ifrs-full:VehiclesMember2026-07-310001715925ifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:TopOfRangeMemberhyft:LabEquipmentMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:FixturesAndFittingsMember2026-04-300001715925ifrs-full:TopOfRangeMemberifrs-full:VehiclesMember2026-05-012026-07-310001715925hyft:OptionTenMember2026-07-3100017159252026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-07-310001715925ifrs-full:RetainedEarningsMember2025-04-300001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2026-04-3000017159252026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2026-04-300001715925country:BE2025-05-012025-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2026-05-012026-07-310001715925ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember2026-07-310001715925ifrs-full:RestrictedShareUnitsMember2026-04-300001715925hyft:NetBookValueMemberifrs-full:BuildingsMember2026-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2026-04-300001715925hyft:OptionNineMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2026-04-300001715925hyft:NetBookValueMember2026-04-300001715925hyft:NetBookValueMemberhyft:InternallyGeneratedDevelopmentCostsMember2026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2026-07-310001715925hyft:NetBookValueMemberifrs-full:LeaseholdImprovementsMember2026-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2025-05-012026-04-300001715925ifrs-full:IssuedCapitalMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2026-07-310001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2025-05-012026-04-300001715925country:NL2026-07-310001715925hyft:LabEquipmentMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2026-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2025-04-300001715925hyft:NetBookValueMemberhyft:IntellectualPropertiesMember2026-04-300001715925hyft:AtTheMarketEquityOfferingFacilityMember2026-07-310001715925hyft:ImmunoPreciseNetherlandsBVMember2025-05-012026-04-300001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:NetBookValueMemberhyft:AutomobileMember2026-07-310001715925hyft:OptionSevenMember2026-05-012026-07-310001715925hyft:AccumulatedAmortizationMember2026-05-012026-07-310001715925ifrs-full:IssuedCapitalMember2025-05-012025-07-310001715925hyft:ImmunoPreciseAntibodiesNDLtdMember2026-05-012026-07-3100017159252025-05-012026-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2026-05-012026-07-310001715925srt:NorthAmericaMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2026-04-300001715925srt:NorthAmericaMemberhyft:CorporateSegmentsMember2026-04-300001715925hyft:ProprietaryProcessesMemberhyft:NetBookValueMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:FixturesAndFittingsMember2025-05-012026-04-300001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2025-04-300001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2025-05-012026-04-300001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2026-07-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:BioKeyBVMember2026-05-012026-07-310001715925hyft:NetBookValueMemberhyft:WorkInProgressLeaseholdImrpvementsMember2026-07-310001715925ifrs-full:RestrictedShareUnitsMember2026-05-012026-07-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2025-04-300001715925hyft:NetBookValueMemberhyft:CertificationsMember2026-07-310001715925hyft:IdeaFamilyBVMember2025-05-012026-04-300001715925hyft:ImmunoPreciseAntibodiesCanadaLtdDBaMindWalkBiologicsMember2026-05-012026-07-310001715925hyft:ImmunoPreciseAntibodiesMALLCMember2026-05-012026-07-310001715925hyft:ProprietaryProcessesMemberhyft:NetBookValueMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2025-05-012026-04-300001715925hyft:NetBookValueMemberhyft:CertificationsMember2026-04-3000017159252022-05-310001715925ifrs-full:RestrictedShareUnitsMember2025-05-012026-04-300001715925hyft:OptionThirteenMember2026-05-012026-07-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:BioClueBVMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2026-07-310001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2026-07-310001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:AccumulatedAmortizationMember2026-07-310001715925hyft:NetBookValueMemberhyft:InternallyGeneratedDevelopmentCostsMember2026-07-310001715925hyft:ProprietaryProcessesMemberhyft:AccumulatedAmortizationMember2026-04-300001715925hyft:CryoStorageMember2025-05-012025-07-310001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2026-04-300001715925country:CA2026-05-012026-07-310001715925ifrs-full:RestrictedShareUnitsMember2025-05-012025-07-310001715925hyft:FindersWarrantsMemberhyft:RangeOneMember2026-05-012026-07-310001715925country:BE2026-07-310001715925ifrs-full:LeaseLiabilitiesMember2026-04-300001715925country:NL2026-04-300001715925ifrs-full:GrossCarryingAmountMember2026-04-300001715925hyft:AllOtherCountriesMember2025-05-012025-07-310001715925hyft:MindWalkBVMember2026-07-310001715925hyft:OptionFiveMember2026-07-310001715925ifrs-full:RetainedEarningsMember2025-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:BuildingsMember2026-05-012026-07-310001715925ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember2026-07-310001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925ifrs-full:LeaseLiabilitiesMember2026-07-3100017159252025-04-300001715925hyft:OptionFiveMember2026-05-012026-07-310001715925hyft:NetBookValueMemberifrs-full:FixturesAndFittingsMember2026-04-300001715925ifrs-full:AdditionalPaidinCapitalMember2025-04-300001715925hyft:BioStrandBVDBAMindWalkMember2026-05-012026-07-310001715925hyft:AtTheMarketEquityOfferingFacilityMember2025-05-012026-04-3000017159252026-04-300001715925ifrs-full:LeaseLiabilitiesMember2025-05-012025-07-310001715925hyft:AtTheMarketEquityOfferingFacilityMember2026-05-012026-07-310001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925hyft:NetBookValueMember2026-07-310001715925country:AU2026-05-012026-07-310001715925ifrs-full:RetainedEarningsMember2025-05-012025-07-310001715925srt:NorthAmericaMember2025-05-012025-07-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2026-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2025-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberhyft:AccumulatedAmortizationMember2026-04-300001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:OptionTwoMember2026-05-012026-07-310001715925ifrs-full:GrossCarryingAmountMemberifrs-full:BuildingsMember2025-05-012026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberifrs-full:LeaseholdImprovementsMember2026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2025-04-300001715925ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember2026-07-310001715925hyft:InternallyGeneratedDevelopmentCostsMemberifrs-full:GrossCarryingAmountMember2026-05-012026-07-3100017159252025-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMember2025-05-012026-04-300001715925hyft:IntellectualPropertiesMemberhyft:AccumulatedAmortizationMember2025-05-012026-04-300001715925hyft:WorkInProgressLeaseholdImrpvementsMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:FindersWarrantsMember2025-04-300001715925ifrs-full:GrossCarryingAmountMember2026-05-012026-07-310001715925hyft:CertificationsMemberifrs-full:GrossCarryingAmountMember2026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2026-07-310001715925ifrs-full:GrossCarryingAmountMember2026-04-300001715925ifrs-full:GrossCarryingAmountMemberifrs-full:LeaseholdImprovementsMember2026-07-310001715925ifrs-full:GrossCarryingAmountMemberhyft:ComputerHardwareMember2025-05-012026-04-3000017159252025-05-012025-07-310001715925hyft:LabEquipmentMemberhyft:NetBookValueMember2026-04-300001715925ifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:LabEquipmentMemberifrs-full:GrossCarryingAmountMember2025-04-300001715925hyft:ImmunoPreciseAntibodiesCanadaLtdDBaMindWalkBiologicsMember2025-05-012026-04-300001715925ifrs-full:NotLaterThanOneYearMember2026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2026-04-300001715925country:US2025-05-012025-07-310001715925hyft:ProjectRevenueMember2026-05-012026-07-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925ifrs-full:RetainedEarningsMember2026-07-3100017159252024-05-012025-04-300001715925hyft:AccumulatedAmortizationMember2026-04-300001715925hyft:ProprietaryProcessesMemberifrs-full:GrossCarryingAmountMember2026-07-310001715925hyft:NetBookValueMemberifrs-full:FixturesAndFittingsMember2026-07-310001715925hyft:IntellectualPropertiesMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925ifrs-full:IssuedCapitalMember2026-07-310001715925hyft:BioKeyBVMember2025-05-012026-04-300001715925ifrs-full:AccumulatedOtherComprehensiveIncomeMember2025-07-310001715925hyft:CryoStorageMember2026-05-012026-07-310001715925hyft:OptionNineMember2026-07-310001715925ifrs-full:BottomOfRangeMemberifrs-full:VehiclesMember2026-05-012026-07-310001715925hyft:NetBookValueMemberhyft:AutomobileMember2026-04-300001715925hyft:OptionThreeMember2026-05-012026-07-310001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:ComputerHardwareMember2025-05-012026-04-300001715925ifrs-full:RetainedEarningsMember2026-04-300001715925hyft:OptionElevenMember2026-05-012026-07-310001715925country:NL2025-05-012025-07-310001715925hyft:OptionTwelveMember2026-05-012026-07-310001715925ifrs-full:AdditionalPaidinCapitalMember2025-07-310001715925hyft:AutomobileMemberifrs-full:GrossCarryingAmountMember2025-05-012026-04-300001715925hyft:AccumulatedAmortizationMemberhyft:CertificationsMember2026-07-310001715925hyft:OptionSevenToTwelveMember2026-07-310001715925hyft:LabEquipmentMemberifrs-full:AccumulatedDepreciationAndAmortisationMember2025-05-012026-04-300001715925ifrs-full:AccumulatedDepreciationAndAmortisationMemberhyft:AutomobileMember2025-05-012026-04-30iso4217:EURxbrli:purexbrli:sharesiso4217:CADiso4217:USD
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of September, 2026.
Commission File Number: 001-39530
MindWalk Holdings Corp.
Industrious 823 Congress Ave Suite 300 Austin, Texas 78701, United States
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
INCORPORATION BY REFERENCE
Exhibits 99.1 and 99.2 of this Form 6-K are incorporated by reference into the Registration Statements on Form S-8 (File Nos. 333-256730 and 333-290949) and Registration Statements on Form F-3 (File Nos. 333-281312 and 333-297424) of the Registrant, MindWalk Holdings Corp.
EXHIBIT INDEX
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
MINDWALK HOLDINGS CORP. |
Date: September 14, 2026 |
|
|
|
|
|
By: |
/s/ Jennifer Bath |
|
Name: |
Jennifer Bath |
|
Title: |
Chief Executive Officer |
ATTACHMENTS / EXHIBITS
EX-99.1
EX-99.2
EX-99.3
EX-99.4
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
IDEA: R1.htm
IDEA: R2.htm
IDEA: R3.htm
IDEA: R4.htm
IDEA: R5.htm
IDEA: R6.htm
IDEA: R7.htm
IDEA: R8.htm
IDEA: R9.htm
IDEA: R10.htm
IDEA: R11.htm
IDEA: R12.htm
IDEA: R13.htm
IDEA: R14.htm
IDEA: R15.htm
IDEA: R16.htm
IDEA: R17.htm
IDEA: R18.htm
IDEA: R19.htm
IDEA: R20.htm
IDEA: R21.htm
IDEA: R22.htm
IDEA: R23.htm
IDEA: R24.htm
IDEA: R25.htm
IDEA: R26.htm
IDEA: R27.htm
IDEA: R28.htm
IDEA: R29.htm
IDEA: R30.htm
IDEA: R31.htm
IDEA: R32.htm
IDEA: R33.htm
IDEA: R34.htm
IDEA: R35.htm
IDEA: R36.htm
IDEA: R37.htm
IDEA: R38.htm
IDEA: R39.htm
IDEA: R40.htm
IDEA: R41.htm
IDEA: R42.htm
IDEA: R43.htm
IDEA: R44.htm
IDEA: R45.htm
IDEA: R46.htm
IDEA: R47.htm
IDEA: R48.htm
IDEA: R49.htm
IDEA: R50.htm
IDEA: R51.htm
IDEA: R52.htm
IDEA: R53.htm
IDEA: R54.htm
IDEA: R55.htm
IDEA: R56.htm
IDEA: FilingSummary.xml
IDEA: MetaLinks.json
IDEA: hyft-20260731_htm.xml